The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, mental retardation, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene.
Immunogen Information
Immunogen
Synthesized peptide derived from human MEK-2 around the non-phosphorylation site of T394.
Swissprot
P36507
Synonyms
Cardiofaciocutaneous syndromeCFC syndromeCFC4Dual specificity mitogen activated protein kinase kinase 2Dual specificity mitogen-activated protein kinase kinase 2ERK activator kinase 2FLJ26075MAP kinase kinase 2map2k2MAPK / ERK kinase 2MAPK/ERK k
Observed MW
45 kDa
Applications
Reactivity
Human,Mouse,Rat
Tested Applications
WB
Conjugation
Unconjugated
Dilution
WB 1:500-1:2000, IHC 1:100-1:300, IP 1:200-1:500, ELISA 1:10000
Concentration
1 mg/mL
Storage Buffer
PBS with 0.02% sodium azide, 0.5% protective protein and 50% glycerol, pH7.4